Clinicopathologic Features of the Severe Form of Acute Type 1 Autoimmune Hepatitis

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 2, 2007, Pages 255-258

  Abe, Masanori ^a   Onji, Morikazu ^a   Kawai Ninomiya, Keiko ^a   Michitaka, Kojiro ^a   Matsuura, Bunzo ^a   Hiasa, Yoichi ^a   Horiike, Norio ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BILIRUBIN; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE;

ADD ON THERAPY; ANALYTIC METHOD; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER; PATHOGENESIS; RETROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BILIRUBIN; FEMALE; GLUCOCORTICOIDS; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 33846805723     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.10.011     Document Type: Article

References (14)

1. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 354 (2006) 54-66
2. Onji M., Nonaka T., Horiike N., et al. Present status of autoimmune hepatitis in Japan. Gastroenterol Jpn 28 Suppl 4 (1993) 134-138
3. Abe M., Hiasa Y., Masumoto T., et al. Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis. Hepatol Res 21 (2001) 213-219
4. Okano N., Yamamoto K., Sakaguchi K., et al. Clinicopathological features of acute-onset autoimmune hepatitis. Hepatol Res 25 (2003) 263-270
5. Nikias G.A., Batts K.P., and Czaja A.J. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 21 (1994) 866-871
6. Ferrari R., Pappas G., Agostinelli D., et al. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the "acute" type. QJM 97 (2004) 407-412
7. Singh R., Nair S., Farr G., et al. Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature. Am J Gastroenterol 97 (2002) 2670-2673
8. Lefkowitch J.H., Apfelbaum T.F., Weinberg L., et al. Acute liver biopsy lesions in early autoimmune ("lupoid") chronic active hepatitis. Liver 4 (1984) 379-386
9. Kessler W.R., Cummings O.W., Eckert G., et al. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2 (2004) 625-631
10. Kawai K., Michitaka K., Miyauchi S., et al. Acute-onset autoimmune hepatitis treated with living donor-liver transplantation. Intern Med 42 (2003) 158-162
11. Toda G., Zeniya M., Watanabe F., et al. Present status of autoimmune hepatitis in Japan: correlating the characteristics with international criteria in an area with a high rate of HCV infection-Japanese National Study Group of Autoimmune Hepatitis. J Hepatol 26 (1997) 1207-1212
12. Alvarez F., Berg P.A., Bianchi F.B., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
13. Trey C., and Davidson C.S. The management of fulminant hepatic failure. In: Popper H., and Schaffner E. (Eds). Progress in liver disease Volume III (1970), Grune & Stratton, New York 282-298
14. Maria V.A.J., and Victorino R.M.M. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 26 (1997) 664-669